◀ Back to MAPK10
MAPK10 — RHOA
Pathways - manually collected, often from reviews:
Text-mined interactions from Literome
Vial et al., Cancer Cell 2003
(Colonic Neoplasms...) :
ERK-MAPK signaling coordinately
regulates activity of Rac1 and
RhoA for tumor cell motility
Calleros et al., Apoptosis 2006
:
Finally, overexpression of the dominant negative
N19RhoA inhibited p38
MAPK phosphorylation and apoptosis induced by low cholesterol levels
Horowitz et al., Am J Physiol Gastrointest Liver Physiol 2007
(Crohn Disease...) :
The
RhoA inhibitor C3 exoenzyme and the ROCK inhibitor Y-27632 both
attenuated TNF-alpha/lipopolysaccharide induced
MAPK activation and blocked AR expression in HIMEC
Yano et al., Circ Res 2007
(Inflammation) :
However,
DN-RhoA and DN-Cdc42
activated p38
MAPK , but not ERK1/2
Zeidan et al., Cardiovasc Res 2008
(Cardiomegaly) :
Leptin induced cardiomyocyte hypertrophy involves selective caveolae and
RhoA/ROCK dependent p38
MAPK translocation to nuclei
Spindler et al., J Immunol 2010
(Disease Models, Animal...) :
Several intracellular signaling pathways, such as
p38MAPK activation and
RhoA inhibition , have been demonstrated to be altered following autoantibody binding and to be causally involved in loss of keratinocyte cohesion
Shatanawi et al., Am J Physiol Cell Physiol 2011
:
ANG II also elevates active
RhoA levels and
induces phosphorylation of p38
MAPK
Moey et al., J Pharmacol Exp Ther 2011
(Cardiomegaly) :
These results demonstrate a potent inhibitory effect of ginseng against leptin induced cardiac hypertrophy, an effect associated with prevention of
p115RhoGEF-RhoA/ROCK dependent p38
MAPK activation